A RARE CLINICAL PRESENTATION: A PATIENT WITH CHRONIC RENAL FAILURE, SECONDARY HYPERPARATHYROIDISM AND CALCIPHYLAXIS

Basit Öğe Kaydı
dc.authoridCelik, Mehmet/0000-0001-7364-370X
dc.authoridAytürk Salt, Semra/0000-0002-1560-3459
dc.authorwosidKüçükarda, Ahmet/AGF-2120-2022
dc.authorwosidCelik, Mehmet/AAA-8773-2021
dc.authorwosidCan, Nuray/D-3452-2016
dc.authorwosidAytürk Salt, Semra/U-4265-2017
dc.contributor.authorCelik, M.
dc.contributor.authorAyturk, S.
dc.contributor.authorCelik, H.
dc.contributor.authorCan, N.
dc.contributor.authorKucukarda, A.
dc.contributor.authorSezer, A.
dc.contributor.authorGuldiken, S.
dc.date.accessioned2024-06-12T10:55:29Z
dc.date.available2024-06-12T10:55:29Z
dc.date.issued2016
dc.departmentTrakya Üniversitesien_US
dc.description.abstractCalciphylaxis, also known as calcific uremic arteriolopathy (CUA), is usually observed in women and it is a serious complication of hyperparathyroidism secondary to chronic renal failure. CUA is characterized by ischemic tissue loss secondary to progressive vascular degeneration. Although it is rare, it may end up with sepsis and organ failure and can be fatal. Its pathogenesis is not fully understood, but it is thought that it occurs secondary to increased calcification activators such as oxidized LDL, TNF-alpha, calcitriol, fibronectin, collagen-I, and TGF-1 alpha. The most effective treatment is managing underlying pathology and decreasing serum calcium and phosphorus levels. In this report, we aimed to present an end stage renal failure case with coexisting hyperparathyroidism, hyperthyroidism and calciphylaxis in whom cutaneous manifestations were healed 6 months after parathyroidectomy.en_US
dc.identifier.doi10.4183/aeb.2016.219
dc.identifier.endpage223en_US
dc.identifier.issn1841-0987
dc.identifier.issn1843-066X
dc.identifier.issue2en_US
dc.identifier.pmid31149090en_US
dc.identifier.scopus2-s2.0-85011967174en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage219en_US
dc.identifier.urihttps://doi.org/10.4183/aeb.2016.219
dc.identifier.urihttps://hdl.handle.net/20.500.14551/19444
dc.identifier.volume12en_US
dc.identifier.wosWOS:000380179000017en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherEditura Acad Romaneen_US
dc.relation.ispartofActa Endocrinologica-Bucharesten_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCalciphylaxisen_US
dc.subjectChronic Renal Failureen_US
dc.subjectHyperparathyroidismen_US
dc.subjectHyperthyroidismen_US
dc.subjectRisk-Factorsen_US
dc.subjectPathogenesisen_US
dc.subjectSurvivalen_US
dc.subjectHormoneen_US
dc.subjectDiseaseen_US
dc.titleA RARE CLINICAL PRESENTATION: A PATIENT WITH CHRONIC RENAL FAILURE, SECONDARY HYPERPARATHYROIDISM AND CALCIPHYLAXISen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu